• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar

Galen Institute

A not-for-profit health and tax policy research organization.

  • Home
  • About Us
    • Mission and History
    • Officers and Trustees
    • Scholars and Staff
    • Who was Galen?
  • Activities
    • Core Activities
    • State Leaders Calls
    • Commentary and Oped Tutorial
    • Our Book
    • Galen Guides
  • Donate
  • Contact Us
  • Major Papers
  • Broadcast Interviews

Ayn Rand Center: Shortage of Drugs, Abundance of Regulations

POSTED BY Galen Institute on February 27, 2012.

There is currently a shortage of more than 200 drugs in the United States. Among the drugs critically in short supply are anesthetics, blood pressure medications and a whole host of cancer-fighting treatments, the shortage of which has tragically left many patients with the grim prospect that they may not survive ailments that are treatable.

Many explanations have been put forth as to what is causing this drug shortage. The New York Times, for example, cites“contamination problems at some manufacturing plants, forcing unexpected production shutdowns, [and] difficulties in getting pharmaceutical ingredients from suppliers, especially those abroad,” as some of the factors that have played a role.

Continue reading…

Filed Under: Uncategorized

Primary Sidebar

NEW – OF INTEREST

Health Care Choices 20/20:

A Vision for the Future


See the latest interview of Grace-Marie Turner on C-SPAN

SEARCH

LATEST NEWSLETTER ISSUES

SUBSCRIBE

Social Media

Like Us On Facebook

Twitter: @galeninstitute

 

Copyright Galen Institute, Inc © 2021; · Log in